Reviews
IMAJ | volume 24
Journal 6, June 2022
pages: 417-420
Cannabis and Autoimmune Diseases
1Ariel University, Ariel, Israel
2Department of Molecular Biology, Ariel University, Israel
3Zabludowicz Center for Autoimmune Diseases and 4Internal Medicine B, Sheba Medical Center, Tel Hashomer, Israel
5Laboratory of the Mosaics of Autoimmunity, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
6Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Summary
Cannabis and cannabinoids have been known for thousands of years for their promising potential as analgesics. Chronic pain is a common complaint among many patients with rheumatic conditions. These disorders have revisited the medical approach toward cannabis and its potential role in pain relief. In addition, in recent years, information has mounted about the immunomodulatory effects of cannabis. In this review we discuss findings on the benefits cannabis may have in rheumatic and autoimmune disorders.